Rx for Biotech

By Podcast Host Chris LeidliBusiness

Rx for Biotech episodes

March 11, 2024 ASGCT Annual Meeting Preview
This episode features a preview of the American Society of Gene and Cell Therapy Annual Meeting scientific symposium on the impact of Generative AI on cell and gene therapy (CGT); best practices and real-world applications for communicators. Dr. Rory Bricker-Anthony shares insight into what attendees can expect to learn from the May 2024 session, including current tools and applications for CGT communicators.
12 min
February 12, 2024 2024 Biopharma Investment Outlook with Chris Dokomajilar
Our guest in this podcast episode is Chris Dokomajilar, Founder and CEO of DealForma. DealForma’s comprehensive life science database includes meticulously researched licensing deal financial comps, up-to-date profiles, and historic company and pipeline data.
In this special spotlight episode, we take a deeper dive into the investment landscape for advanced therapies and also AI investment and partnership activity in the biopharma space.
20 min
January 11, 2024 How one Survivor beat the odds against Mucosal Melanoma
We often don’t get the chance to hear from survivors and patient advocates whose lives have been impacted by advanced medicines; so that makes this podcast episode special as we talk to Chris White, a cancer survivor who faced the unimaginable when diagnosed with Mucosal Melanoma in 2018—a rare and aggressive cancer which makes Chris's journey even more exceptional.
Today, Chris is not just a survivor; he's a beacon of inspiration. He has redirected his energy towards advocacy, prevention, and raising awareness of the complexities associated with Mucosal Melanoma.
Tune in to listen to Chris's extraordinary odyssey, exploring the challenges he faced throughout his treatment journey and proving that with resilience, determination, and hope, anything is possible.
33 min
January 04, 2024 Mark Carbone on How Respiratory Muscle Training can improve Cardiopulmonary Outcomes
Our guest for this podcast episode is Mark Carbone, the CEO of PN Medical.
PN Medical is a leader in respiratory care and research. The company created “The Breather”, the world’s first combined respiratory muscle training device to strengthen respiratory muscles to optimize blood flow, lung function and strengthen the cardiopulmonary system.
30 min
December 19, 2023 Episode 2: Future Advances in Cell Therapy Analytics
In part 2 of this special round table podcast series, we discuss the future trends and advances in cell therapy manufacturing and the impact of AI on the evolving cell therapy analytics space.
20 min
December 10, 2023 Episode 1: Current Advancements in Cell Therapy Analytics
In part 1 of this special round table podcast series, we discuss the current trends and advances in cell therapy manufacturing and the impact of evolving manufacturing processes on the analytics space.
42 min
October 11, 2023 Health Policy Update: IRA, 340b Drug Pricing and PBMs
Our guest for this podcast episode is Laura Hobbs, Director of Healthcare Policy at the American Action Forum.
In this episode, we discuss the Inflation Reduction Act impact on Pharma and Patient Access, along with 340b drug pricing and new PBM utilization controls.
Learn more about the American Action Forum, and subscribe to their weekly newsletter here: https://www.americanactionforum.org/
27 min
September 24, 2023 Special Episode: ASGCT Policy Summit Highlights
In this special episode, listen to Emily Walsh Martin, PhD, Principal at Tremont Therapeutics Consulting, as she shares some of the key highlights from the American Society of Gene and Cell Therapy’s Policy Summit that was held in Washington, DC, on September 18th and 19th, 2023.
Check out the full program and register to view the on-demand content online at asgct.org/advocacy/policy-summit/agenda
26 min
September 21, 2023 The IRA 1-year Anniversary Episode: What Lies Ahead?
The Inflation Reduction Act was signed into law in August 2022. In this podcast episode, we look into what lies ahead as the policy implementation begins. Our guest in this episode is Dr. Robert Popovian, a clinical pharmacist and health economist with deep expertise in health policy, drug pricing and affordability, access, and patient advocacy.
33 min
September 19, 2023 Developing Best-in-Class Radiopharmaceuticals for Cancer Patients
Our guests for this podcast episode are the co-founders of Ratio Therapeutics, CEO Jack Hoppin, PhD, and Chief Scientific Officer, John Babich, PhD.
Ratio Therapeutics's mission is to develop best-in-class radiopharmaceuticals for the treatment of cancers.
29 min

About Rx for Biotech

From the publisher's feed

"Rx for Biotech" is a healthcare education podcast dedicated to helping patients, caregivers, and healthcare professionals understand the rapidly evolving world of advanced therapies - and how patients can access them. From cell therapies and gene therapies to radiopharmaceuticals, immunotherapies, and next-generation treatments for cancer and autoimmune disease, this channel bridges the gap between breakthrough science and real-world patient care.